SILO PHARMA, INC. Other Comprehensive Income (Loss), Net of Tax
SILO PHARMA, INC. (SILO) reported Other Comprehensive Income (Loss), Net of Tax of -$18.08 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2024-08-13
- SILO PHARMA, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was -$18.08K.
- SILO PHARMA, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was $32.33K, a 517.12% increase year-over-year.
- SILO PHARMA, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-09-30 was $2.56K.
- SILO PHARMA, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-06-30 was -$8.52K.
- SILO PHARMA, INC. other comprehensive income (loss), net of tax for fiscal 2023 was -$6.23K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$18.08K 10-Q · filed 2024-08-13 | $14.25K derived: sum of 2 quarters · filed 2024-08-13 | ||
| 2024-03-31 | $32.33K 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | -$6.23K 10-K · filed 2024-03-25 | |||
| 2023-09-30 | $2.56K 10-Q · filed 2023-11-13 | -$5.96K derived: sum of 2 quarters · filed 2024-08-13 | -$723.00 derived: sum of 3 quarters · filed 2024-08-13 | |
| 2023-06-30 | -$8.52K 10-Q · filed 2024-08-13 | -$3.28K derived: sum of 2 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $5.24K 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |